HHS’ Adverse Drug Event Action Plan Calls For New Treatment Guidelines
This article was originally published in The Pink Sheet Daily
Executive Summary
Draft recommends research and initiatives that could lead to changes in drug prescribing practices to reduce the likelihood of adverse drug events – and may even include more prescribing if adverse drug events can be mitigated.